Immunotherapy, Genomic Profiling and Potential Game Changing Drugs Lead List of 2014 Dana-Farber Research Highlights

This press release describes highlights of the Dana-Farber Cancer Institute 2014 cancer research and clinical developments, including work in immunotherapy, genomic profiling, and investigating game-changing drug therapies. Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center is one of the 25 NCCN Member Institutions. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news